Expertise in
2
conditions

Bradley S. Quon

St. Paul's Hospital, 
Vancouver, BC, CA 
Expertise in
2
conditions
St. Paul's Hospital, 
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Bradley Quon practices in Vancouver, Canada. Mr. Quon is highly rated in 2 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Allergic Bronchopulmonary Aspergillosis, Pseudomonas Stutzeri Infections, Lung Transplant, and Heart Transplant.

His clinical research consists of co-authoring 121 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

St. Paul's Hospital, Vancouver, BC, Canada
Other Locations
#31-795 West 8th Avenue, V5Z 1C9, Vancouver, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
Randomized Controlled Trial of Prednisone in Cystic Fibrosis Pulmonary Exacerbations
Randomized Controlled Trial of Prednisone in Cystic Fibrosis Pulmonary Exacerbations
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drug: Prednisone
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
A Phase 1b Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
A Phase 1b Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: April 13, 2022
Intervention Type: Drug
Study Drug: CB-280 Arginase Inhibitor
Study Phase: Phase 1
View 3 Less Clinical Trials

121 Total Publications

Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis.
Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis.
Journal: Annals of medicine
Published: June 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Quon's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile